Ependymoma in the Children

  • Shobhan Vachhrajani
  • Corey RaffelEmail author


Ependymomas are rare tumors of neuroectodermal origin. Pediatric ependymomas, the focus of this chapter, are found primarily intracranially. Two-thirds of these are found infratentorially. Surgical resection remains the foundation of therapy for these tumors, and surgeons have to balance the goals of complete resection with minimizing postoperative neurological deficit given adherence to vital neurologic structures. Radiation is a commonly employed adjuvant therapy and is the standard of care for posterior fossa ependymomas in children. Chemotherapy continues to show little benefit for this disease. A new molecular classification has been recently validated and holds great promise for the accurate diagnosis and management of pediatric ependymoma, with potential for novel therapeutic targets that may improve prognosis in an otherwise difficult to manage tumor.


Ependymoma Pediatric Posterior fossa Brain tumor Molecular classification Tumor genetics Surgery Radiation therapy 


  1. 1.
    Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P et al (2005) Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8(4):323–335PubMedCrossRefGoogle Scholar
  2. 2.
    Kilday JP, Rahman R, Dyer S, Ridley L, Lowe J, Coyle B et al (2009) Pediatric ependymoma: biological perspectives. Mol Cancer Res 7(6):765–786PubMedCrossRefGoogle Scholar
  3. 3.
    Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J et al (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro-Oncology 16(Suppl 4):iv1–i63PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    McGuire CS, Sainani KL, Fisher PG (2009) Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study. J Neurosurg 110(4):725–729PubMedCrossRefGoogle Scholar
  5. 5.
    Dorfer C, Tonn J, Rutka JT (2016) Ependymoma. a heterogeneous tumor of uncertain origin and limited therapeutic options Handb Clin Neurol 134:417–431PubMedGoogle Scholar
  6. 6.
    Pajtler KW, Mack SC, Ramaswamy V, Smith CA, Witt H, Smith A et al (2017) The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants. Acta Neuropathol 133(1):5–12PubMedCrossRefGoogle Scholar
  7. 7.
    Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL (1992) DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 326(15):988–993PubMedCrossRefGoogle Scholar
  8. 8.
    Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F et al (2015) Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27(5):728–743PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    McLendon RE, Lipp E, Satterfield D, Ehinger M, Austin A, Fleming D et al (2015) Prognostic marker analysis in pediatric intracranial ependymomas. J Neurooncol 122(2):255–261PubMedCrossRefGoogle Scholar
  10. 10.
    Preusser M, Wolfsberger S, Haberler C, Breitschopf H, Czech T, Slavc I et al (2005) Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival. Acta Neuropathol 109(2):211–216PubMedCrossRefGoogle Scholar
  11. 11.
    Snuderl M, Chi SN, De Santis SM, Stemmer-Rachamimov AO, Betensky RA, De Girolami U et al (2008) Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas. J Neuropathol Exp Neurol 67(9):911–920PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Wagemakers M, Sie M, Hoving EW, Molema G, de Bont ES, den Dunnen WF (2010) Tumor vessel biology in pediatric intracranial ependymoma. J Neurosurg Pediatr 5(4):335–341PubMedCrossRefGoogle Scholar
  13. 13.
    Allen JC, Siffert J, Hukin J (1998) Clinical manifestations of childhood ependymoma: a multitude of syndromes. Pediatr Neurosurg 28(1):49–55PubMedCrossRefGoogle Scholar
  14. 14.
    Yuh EL, Barkovich AJ, Gupta N (2009) Imaging of ependymomas: MRI and CT. Childs Nerv Syst 25(10):1203–1213PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Salazar OM (1983) A better understanding of CNS seeding and a brighter outlook for postoperatively irradiated patients with ependymomas. Int J Radiat Oncol Biol Phys 9(8):1231–1234PubMedCrossRefGoogle Scholar
  16. 16.
    Qian X, Goumnerova LC, De Girolami U, Cibas ES (2008) Cerebrospinal fluid cytology in patients with ependymoma: a bi-institutional retrospective study. Cancer 114(5):307–314PubMedCrossRefGoogle Scholar
  17. 17.
    Figarella-Branger D, Civatte M, Bouvier-Labit C, Gouvernet J, Gambarelli D, Gentet JC et al (2000) Prognostic factors in intracranial ependymomas in children. J Neurosurg 93(4):605–613PubMedCrossRefGoogle Scholar
  18. 18.
    Choudhri AF, Siddiqui A, Klimo P Jr (2016) Pediatric cerebellar tumors: emerging imaging techniques and advances in understanding of genetic features. Magn Reson Imaging Clin N Am 24(4):811–821PubMedCrossRefGoogle Scholar
  19. 19.
    Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Muracciole X et al (2016) Prognostic and predictive values of diffusion and perfusion MRI in paediatric intracranial ependymomas in a large national study. Br J Radiol 89(1066):20160537PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Arle JE, Morriss C, Wang ZJ, Zimmerman RA, Phillips PG, Sutton LN (1997) Prediction of posterior fossa tumor type in children by means of magnetic resonance image properties, spectroscopy, and neural networks. J Neurosurg 86(5):755–761PubMedCrossRefGoogle Scholar
  21. 21.
    Schneider JF, Confort-Gouny S, Viola A, Le Fur Y, Viout P, Bennathan M et al (2007) Multiparametric differentiation of posterior fossa tumors in children using diffusion-weighted imaging and short echo-time 1H-MR spectroscopy. J Magn Reson Imaging 26(6):1390–1398PubMedCrossRefGoogle Scholar
  22. 22.
    Raghunathan A, Wani K, Armstrong TS, Vera-Bolanos E, Fouladi M, Gilbertson R et al (2013) Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system. Brain Pathol 23(5):584–594PubMedCrossRefGoogle Scholar
  23. 23.
    Pfister S, Hartmann C, Korshunov A (2009) Histology and molecular pathology of pediatric brain tumors. J Child Neurol 24(11):1375–1386PubMedCrossRefGoogle Scholar
  24. 24.
    Sobel EL, Gilles FH, Leviton A, Tavare CJ, Hedley-Whyte ET, Rorke LB et al (1996) Survival of children with infratentorial neuroglial tumors. The childhood brain tumor consortium. Neurosurgery 39(1):45–54. discussion -6PubMedCrossRefGoogle Scholar
  25. 25.
    Ellison DW, Kocak M, Figarella-Branger D, Felice G, Catherine G, Pietsch T et al (2011) Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed 10:7PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Tihan T, Zhou T, Holmes E, Burger PC, Ozuysal S, Rushing EJ (2008) The prognostic value of histological grading of posterior fossa ependymomas in children: a Children’s Oncology Group study and a review of prognostic factors. Mod Pathol 21(2):165–177PubMedCrossRefGoogle Scholar
  28. 28.
    Witt H, Mack SC, Ryzhova M, Bender S, Sill M, Isserlin R et al (2011) Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20(2):143–157PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Carter M, Nicholson J, Ross F, Crolla J, Allibone R, Balaji V et al (2002) Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer 86(6):929–939PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Dyer S, Prebble E, Davison V, Davies P, Ramani P, Ellison D et al (2002) Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am J Pathol 161(6):2133–2141PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M et al (2010) Molecular staging of intracranial ependymoma in children and adults. J Clin Oncol 28(19):3182–3190PubMedCrossRefGoogle Scholar
  32. 32.
    Parker M, Mohankumar KM, Punchihewa C, Weinlich R, Dalton JD, Li Y et al (2014) C11orf95-RELA fusions drive oncogenic NF-kappaB signalling in ependymoma. Nature 506(7489):451–455PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Wani K, Armstrong TS, Vera-Bolanos E, Raghunathan A, Ellison D, Gilbertson R et al (2012) A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol 123(5):727–738PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB et al (2010) Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466(7306):632–636PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW et al (2016) Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa Ependymoma in the molecular era: a retrospective multicohort analysis. J Clin Oncol 34(21):2468–2477PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Pollack IF, Gerszten PC, Martinez AJ, Lo KH, Shultz B, Albright AL et al (1995) Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 37(4):655–666; discussion 66-7PubMedCrossRefGoogle Scholar
  37. 37.
    Rousseau P, Habrand JL, Sarrazin D, Kalifa C, Terrier-Lacombe MJ, Rekacewicz C et al (1994) Treatment of intracranial ependymomas of children: review of a 15-year experience. Int J Radiat Oncol Biol Phys 28(2):381–386PubMedCrossRefGoogle Scholar
  38. 38.
    Shu HK, Sall WF, Maity A, Tochner ZA, Janss AJ, Belasco JB et al (2007) Childhood intracranial ependymoma: twenty-year experience from a single institution. Cancer 110(2):432–441PubMedCrossRefGoogle Scholar
  39. 39.
    Riva-Cambrin J, Detsky AS, Lamberti-Pasculli M, Sargent MA, Armstrong D, Moineddin R et al (2009) Predicting postresection hydrocephalus in pediatric patients with posterior fossa tumors. J Neurosurg Pediatr 3(5):378–385PubMedCrossRefGoogle Scholar
  40. 40.
    Massimino M, Solero CL, Garre ML, Biassoni V, Cama A, Genitori L et al (2011) Second-look surgery for ependymoma: the Italian experience. J Neurosurg Pediatr 8(3):246–250PubMedCrossRefGoogle Scholar
  41. 41.
    Cochrane DD, Gustavsson B, Poskitt KP, Steinbok P, Kestle JR (1994) The surgical and natural morbidity of aggressive resection for posterior fossa tumors in childhood. Pediatr Neurosurg 20(1):19–29PubMedCrossRefGoogle Scholar
  42. 42.
    Doxey D, Bruce D, Sklar F, Swift D, Shapiro K (1999) Posterior fossa syndrome: identifiable risk factors and irreversible complications. Pediatr Neurosurg 31(3):131–136PubMedCrossRefGoogle Scholar
  43. 43.
    Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA (2009) Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol 10(3):258–266PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Merchant TE, Mulhern RK, Krasin MJ, Kun LE, Williams T, Li C et al (2004) Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 22(15):3156–3162PubMedCrossRefGoogle Scholar
  45. 45.
    Bouffet E, Hawkins CE, Ballourah W, Taylor MD, Bartels UK, Schoenhoff N et al (2012) Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation. Int J Radiat Oncol Biol Phys 83(5):1541–1548PubMedCrossRefGoogle Scholar
  46. 46.
    Merchant TE, Bendel AE, Sabin N, Burger PC, Wu S, Boyett JM (2015) A phase II trial of conformal radiation therapy for pediatric patients with localized ependymoma, chemotherapy prior to second surgery for incompletely resected ependymoma and observation for completely resected, differentiated, supratentorial ependymoma. Int J Radiat Oncol Biol Phys 93(3):S1CrossRefGoogle Scholar
  47. 47.
    Macdonald SM, Sethi R, Lavally B, Yeap BY, Marcus KJ, Caruso P et al (2013) Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients. Neuro-Oncology 15(11):1552–1559PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Sato M, Gunther JR, Mahajan A, Jo E, Paulino AC, Adesina AM et al (2017) Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy. Cancer 123(13):2570–2578PubMedCrossRefGoogle Scholar
  49. 49.
    Ares C, Albertini F, Frei-Welte M, Bolsi A, Grotzer MA, Goitein G et al (2016) Pencil beam scanning proton therapy for pediatric intracranial ependymoma. J Neurooncol 128(1):137–145PubMedCrossRefGoogle Scholar
  50. 50.
    Grundy RG, Wilne SA, Weston CL, Robinson K, Lashford LS, Ironside J et al (2007) Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. Lancet Oncol 8(8):696–705PubMedCrossRefGoogle Scholar
  51. 51.
    Merchant TE, Boop FA, Kun LE, Sanford RA (2008) A retrospective study of surgery and reirradiation for recurrent ependymoma. Int J Radiat Oncol Biol Phys 71(1):87–97PubMedCrossRefGoogle Scholar
  52. 52.
    Kano H, Yang HC, Kondziolka D, Niranjan A, Arai Y, Flickinger JC et al (2010) Stereotactic radiosurgery for pediatric recurrent intracranial ependymomas. J Neurosurg Pediatr 6(5):417–423PubMedCrossRefGoogle Scholar
  53. 53.
    Ghia AJ, Mahajan A, Allen PK, Armstrong TS, Lang FF Jr, Gilbert MR et al (2013) Supratentorial gross-totally resected non-anaplastic ependymoma: population based patterns of care and outcomes analysis. J Neurooncol 115(3):513–520PubMedCrossRefGoogle Scholar
  54. 54.
    Venkatramani R, Dhall G, Patel M, Grimm J, Hawkins C, McComb G et al (2012) Supratentorial ependymoma in children: to observe or to treat following gross total resection? Pediatr Blood Cancer 58(3):380–383PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of NeurosurgeryDayton Children’s HospitalDaytonUSA
  2. 2.Boonshoft School of MedicineWright State UniversityDaytonUSA
  3. 3.Department of Neurological SurgeryUniversity of California, San FranciscoSan FranciscoUSA

Personalised recommendations